Published in Circulation on February 01, 2000
Nutritional management of a patient with obesity and pulmonary embolism: a case report. Nutr J (2016) 1.38
Myocardial infarction with angiographically normal coronary arteries. J R Soc Med (2002) 1.15
Hyperhomocysteinemia in renal diseases. J Med Life (2010) 0.85
Homocysteine affects cardiomyocyte viability: concentration-dependent effects on reversible flip-flop, apoptosis and necrosis. Apoptosis (2007) 0.84
Plasma homocysteine and lipoprotein (a) levels in Turkish patients with metabolic syndrome. Heart Vessels (2005) 0.83
The relationship between 25-hydroxyvitamin D and homocysteine in asymptomatic adults. J Clin Endocrinol Metab (2013) 0.81
Homocysteine and asymmetric dimethylarginine in relation to B vitamins in elderly people. Wien Klin Wochenschr (2011) 0.80
Acute and convalescent changes in plasma homocysteine concentrations in acute coronary syndromes. Heart (2001) 0.80
Acute Myocardial Infarction in a Young Lady due to Vitamin B12 Deficiency Induced Hyperhomocysteinemia. Heart Views (2015) 0.77
Association between Stable Coronary Artery Disease and In Vivo Thrombin Generation. Cardiol Res Pract (2016) 0.75
Academic calculations versus clinical judgments: practicing physicians' use of quantitative measures of test accuracy. Am J Med (1998) 3.36
Mechanisms of thrombin generation during surgery and cardiopulmonary bypass. Blood (1993) 1.69
Thrombomodulin gene mutations associated with myocardial infarction. Circulation (1997) 1.67
A comparison of risk stratification schemes for stroke in 79,884 atrial fibrillation patients in general practice. J Thromb Haemost (2011) 1.62
Adjusted prognostic association of depression following myocardial infarction with mortality and cardiovascular events: individual patient data meta-analysis. Br J Psychiatry (2013) 1.58
Matrix metalloproteinases and their tissue inhibitors in hypertension-related pregnancy complications. J Hum Hypertens (2012) 1.49
Anticoagulant activities of heparin oligosaccharides and their neutralization by platelet factor 4. Biochem J (1984) 1.49
Prediction of hemorrhagic transformation following acute stroke: role of diffusion- and perfusion-weighted magnetic resonance imaging. Arch Neurol (2001) 1.48
Relationship between severity of MR perfusion deficit and DWI lesion evolution. Neurology (2001) 1.36
Acquired dysfibrinogenaemia in acute and chronic liver disease. Br J Haematol (1977) 1.30
The central role of thrombin in hemostasis. J Thromb Haemost (2007) 1.26
The effect of heparin on the inositol 1,4,5-trisphosphate receptor in rat liver microsomes. Dependence on sulphate content and chain length. FEBS Lett (1989) 1.23
Assessing methods for causality assessment of suspected adverse drug reactions. J Clin Epidemiol (1989) 1.22
Troponin T for the differential diagnosis of ischaemic myocardial damage. Ann Clin Biochem (1993) 1.21
On site determination of Sulfotep air levels in a fumigating greenhouse. Am Ind Hyg Assoc J (1980) 1.15
Neutralization of heparin-related saccharides by histidine-rich glycoprotein and platelet factor 4. J Biol Chem (1986) 1.13
Early 'rule-in' diagnosis of acute myocardial infarction 4 h post admission for rapid risk stratification by creatine kinase increment (creatine kinase change). Ann Clin Biochem (1996) 1.10
The factor XIII V34L polymorphism accelerates thrombin activation of factor XIII and affects cross-linked fibrin structure. Blood (2000) 1.08
Epidemiology of coagulation factors, inhibitors and activation markers: the Third Glasgow MONICA Survey. I. Illustrative reference ranges by age, sex and hormone use. Br J Haematol (1997) 1.08
Prevalence of the ADAMTS-13 missense mutation R1060W in late onset adult thrombotic thrombocytopenic purpura. J Thromb Haemost (2007) 1.08
Evidence that high von Willebrand factor and low ADAMTS-13 levels independently increase the risk of a non-fatal heart attack. J Thromb Haemost (2008) 1.07
Effect of a new non-steroidal anti-inflammatory drug, nitroflurbiprofen, on the expression of inducible nitric oxide synthase in rat neutrophils. Br J Pharmacol (1995) 1.07
Antithrombin and its inherited deficiency states. Semin Hematol (1997) 1.06
Are troponins confusing? Heart (2003) 1.05
A heparin analogue with specific action on antithrombin III. Lancet (1977) 1.05
Molecular mechanisms involved in the resistance of fibrin to clot lysis by plasmin in subjects with type 2 diabetes mellitus. Diabetologia (2006) 1.04
Factor V Leiden (FV R506Q) in families with inherited antithrombin deficiency. Thromb Haemost (1996) 1.04
Relationship between apparent diffusion coefficient and subsequent hemorrhagic transformation following acute ischemic stroke. Stroke (2000) 1.01
Methylenetetrahydrofolate reductase 677 C-->T mutation and coronary heart disease risk in UK Indian Asians. Arterioscler Thromb Vasc Biol (2000) 1.00
Comparison of the CHADS2, CHA2DS2-VASc and HAS-BLED scores for the prediction of clinically relevant bleeding in anticoagulated patients with atrial fibrillation: the AMADEUS trial. Thromb Haemost (2013) 1.00
Relationship between anticoagulant activities and polyanionic properties of rabbit thrombomodulin. J Biol Chem (1988) 0.97
The effect of blood coagulation factor XIII on fibrin clot structure and fibrinolysis. J Thromb Haemost (2014) 0.96
Rapid troponin T measurement in whole blood for detection of myocardial damage. Ann Clin Biochem (1995) 0.96
Rapid enzyme diagnosis of patients with acute chest pain reduces patient stay in the coronary care unit. Ann Clin Biochem (1993) 0.96
Binding of platelet factor 4 to heparin oligosaccharides. Biochem J (1983) 0.96
The maternal perspective on prenatal ultrasound. J Fam Pract (2000) 0.96
Inhibition by sodium nitroprusside of the expression of inducible nitric oxide synthase in rat neutrophils. Br J Pharmacol (1995) 0.96
Assessment of hypercoagulable states by measurement of activation fragments and peptides. Blood Rev (1990) 0.95
Right ventricular infarction complicated by right to left shunting through an atrial septal defect: successful treatment with an Amplatzer septal occluder. Heart (2005) 0.94
Thrombin-induced fibrinopeptide B release from normal and variant fibrinogens: influence of inhibitors of fibrin polymerization. Biochim Biophys Acta (1988) 0.93
Epidemiology of coagulation factors, inhibitors and activation markers: The Third Glasgow MONICA Survey. II. Relationships to cardiovascular risk factors and prevalent cardiovascular disease. Br J Haematol (1997) 0.93
Characterization of serum fibrinogen and fibrin fragments produced during disseminated intravascular coagulation. Br J Haematol (1978) 0.93
The prognostic value of serum troponin T in unstable angina. N Engl J Med (1992) 0.93
Thrombin production, inactivation and expression during open heart surgery measured by assays for activation fragments including a new ELISA for prothrombin fragment F1 + 2. Thromb Haemost (1993) 0.92
Relationship between ex vivo anti-proteinase (factor Xa and thrombin) assays and in vivo anticoagulant effect of very low molecular weight heparin, CY222. Br J Haematol (1988) 0.91
Changes in several neutrophil functions in basketball players before, during and after the sports season. Int J Sports Med (1995) 0.91
Characterization of peptides cleaved by plasmin from the C-terminal polymerization domain of human fibrinogen. J Biol Chem (1985) 0.91
Proteolysis of the endothelial cell protein C receptor by neutrophil proteinase 3. J Thromb Haemost (2007) 0.91
Anticoagulant activities of four unfractionated and fractionated heparins. Thromb Res (1978) 0.90
Antithrombin: structure, genomic organization, function and inherited deficiency. Baillieres Clin Haematol (1989) 0.90
Measurement of serum troponin T, creatine kinase MB isoenzyme, and total creatine kinase following arduous physical training. Ann Clin Biochem (1995) 0.90
Thrombin-induced fibrinopeptide release from a fibrinogen variant (fibrinogen Sydney I) with an Aalpha Arg-16----His substitution. Eur J Biochem (1985) 0.90
Performance of broiler chickens supplemented with Bacillus coagulans as probiotic. Br Poult Sci (1998) 0.90
Role of factor XII in thrombin generation and fibrinolysis during cardiopulmonary bypass. Lancet (1994) 0.90
GAMT deficiency: features, treatment, and outcome in an inborn error of creatine synthesis. Neurology (2006) 0.90
Feasibility of prenatal diagnosis of lysinuric protein intolerance by linkage analysis: a case report. Prenat Diagn (1999) 0.89
Altered expression of 3 alpha-hydroxysteroid dehydrogenases in human glaucomatous optic nerve head astrocytes. Neurobiol Dis (2003) 0.89
Single amino acid substitutions in the reactive site of antithrombin leading to thrombosis. Congenital substitution of arginine 393 to cysteine in antithrombin Northwick Park and to histidine in antithrombin Glasgow. J Biol Chem (1988) 0.89
Formation of a covalent disulfide-linked antithrombin-albumin complex by an antithrombin variant, antithrombin "Northwick Park". J Biol Chem (1987) 0.89
A comparative evaluation of assays for markers of activated coagulation and/or fibrinolysis: thrombin-antithrombin complex, D-dimer and fibrinogen/fibrin fragment E antigen. Br J Haematol (1990) 0.88
The elderly on dialysis: some considerations in compliance. Am J Kidney Dis (1990) 0.88
Homozygous antithrombin deficiency type II (99 Leu to Phe mutation) and childhood thromboembolism. Thromb Haemost (2001) 0.88
Non-anticoagulant uses of heparin. N Engl J Med (1993) 0.88
Behavioral evidence linking opioid-sensitive GABAergic neurons in the ventrolateral periaqueductal gray to morphine tolerance. Neuroscience (2003) 0.88
Antithrombin: molecular basis of deficiency. Thromb Haemost (1997) 0.87
Pharmacokinetics of a new nitroderivative of acetylsalicylic acid after a single dose in rats. Life Sci (1997) 0.87
A mutation in the thrombomodulin gene, 127G to A coding for Ala25Thr, and the risk of myocardial infarction in men. Thromb Haemost (1998) 0.87
RCPE UK Consensus Conference on 'Approaching the comprehensive management of atrial fibrillation: evolution or revolution?'. J R Coll Physicians Edinb (2012) 0.87
Atrial fibrillation as a risk factor for cognitive impairment: a semi-systematic review. QJM (2013) 0.87
Anti-thrombin activities of heparin. Effect of saccharide chain length on thrombin inhibition by heparin cofactor II and by antithrombin. Biochem J (1989) 0.87
Identification of nine novel mutations in type I antithrombin deficiency by heteroduplex screening. Br J Haematol (1993) 0.86
Detection of enhanced in vivo platelet alpha-granule release in different patient groups--comparison of beta-thromboglobulin, platelet factor 4 and thrombospondin assays. Thromb Haemost (1984) 0.86
Modified APC resistance assay for patients on oral anticoagulants. Lancet (1994) 0.86
Complete nucleotide sequence of the antithrombin gene: evidence for homologous recombination causing thrombophilia. Biochemistry (1993) 0.86
Anti-inflammatory potency and gastrointestinal toxicity of a new compound, nitronaproxen. Pharmacol Res (1995) 0.86
Is migraine associated with right-to-left shunt a separate disease? Results of the SAM study. Cephalalgia (2008) 0.85
Causal propositions in clinical research and practice. J Clin Epidemiol (1992) 0.85
Neutralization of heparin in plasma by platelet factor 4 and protamine sulphate. Br J Haematol (1978) 0.85
Cardiac troponins in patients with renal dysfunction. Ann Clin Biochem (1998) 0.85
Thrombotic risk during pregnancy and puerperium in women with APC-resistance--effective subcutaneous heparin prophylaxis in a pregnant patient. Thromb Haemost (1995) 0.85
Expanding CEP290 mutational spectrum in ciliopathies. Am J Med Genet A (2009) 0.85
Routine versus aggressive upstream rhythm control for prevention of early atrial fibrillation in heart failure: background, aims and design of the RACE 3 study. Neth Heart J (2013) 0.84
Dabigatran adherence in atrial fibrillation patients during the first year after diagnosis: a nationwide cohort study. J Thromb Haemost (2015) 0.84
Factor V Leiden gene mutation and thrombin generation in relation to the development of acute stroke. Arterioscler Thromb Vasc Biol (1995) 0.84
Hyperprolactinemia and psychological distress in women undergoing chronic hemodialysis. Psychother Psychosom (1988) 0.84
Antithrombin: the principal inhibitor of thrombin. Semin Thromb Hemost (1994) 0.84